{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:13:46Z","timestamp":1780319626548,"version":"3.54.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1054\/blre.2001.0162","type":"journal-article","created":{"date-parts":[[2003,2,17]],"date-time":"2003-02-17T22:30:48Z","timestamp":1045521048000},"page":"159-166","source":"Crossref","is-referenced-by-count":71,"title":["Thrombocytosis and thrombocythemia"],"prefix":"10.1054","volume":"15","author":[{"given":"A.I.","family":"Schafer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1054\/blre.2001.0162_RF1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9343(94)90150-3","article-title":"Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases","volume":"96","author":"Buss","year":"1994","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0162_RF2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0002-9343(98)00090-4","article-title":"Blood thrombopoietin levels in clonal thrombocytosis","volume":"4","author":"Wang","year":"1998","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0162_RF3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0022-2143(99)90154-3","article-title":"Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis","volume":"134","author":"Hsu","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1054\/blre.2001.0162_RF4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood.V92.4.1091","article-title":"Familial essential thrombocythemia associated with one-base deletion in the 5'-untranslated region of the thrombopoietin gene","volume":"92","author":"Kondo","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ng0198-49","article-title":"An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia","volume":"18","author":"Wiestner","year":"1998","journal-title":"Nature Genetics"},{"key":"10.1054\/blre.2001.0162_RF6","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/blood.V94.4.1480","article-title":"A single-base deletion in the thrombopoietin (TPO) gene causes familial essential thrombocythemia through a mechanism of more efficient translation of TPO mRNA","volume":"94","author":"Ghilardi","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00062752-200005000-00003","article-title":"Measurement of thrombopoietic levels: clinical and biological relationships","volume":"7","author":"Verbeek","year":"2000","journal-title":"Curr Op Hematol"},{"key":"10.1054\/blre.2001.0162_RF8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2141.2000.02169.x","article-title":"Hereditary thrombocythaemia is a genetically heterogeneous disorder: exclusion of TPO and MPL in two families with hereditary thrombocythaemia","volume":"110","author":"Wiestner","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2141.2001.02565.x","article-title":"Familial thrombocytosis as a recessive, possibly X-linked trait in an Arab family","volume":"112","author":"Stuhrmann","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I","article-title":"Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976\u20131995","volume":"61","author":"Mesa","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0162_RF11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0145-2126(00)00131-4","article-title":"Recent progress in the pathogenesis and management of essential thrombocythemia","volume":"25","author":"Tefferi","year":"2001","journal-title":"Leukemia Res"},{"key":"10.1054\/blre.2001.0162_RF12","unstructured":"Schafer, A. I.Thrombocytosis and essential thrombocythemia. In: Beutler, E., Lichtman, M. A., Coller, B. S., Kipps, T. J., Seligsohn, U. eds. Williams Hematology Vol 6. New York, NY, McGraw-Hill; 2001: 1541\u20131549."},{"key":"10.1054\/blre.2001.0162_RF13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2141.1999.01545.x","article-title":"Essential thrombocythaemia in children","volume":"107","author":"Dror","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1046\/j.1365-2141.2000.02270-7.x","article-title":"Essential thrombocythaemia in children: a recent report of nine cases","volume":"110","author":"Yang","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199809103391107","article-title":"Thrombopoietin","volume":"339","author":"Kaushansky","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0162_RF16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1046\/j.1365-2141.1998.00747.x","article-title":"Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes","volume":"101","author":"Hou","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood.V89.1.101","article-title":"Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization","volume":"89","author":"Sungaran","year":"1997","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-2141.1997.4633267.x","article-title":"Thrombopoietin measurement in thrombocytosis: dysregulation and lack of feedback inhibition in essential thrombocythaemia","volume":"99","author":"Pitcher","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0002-9343(98)00090-4","article-title":"Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis","volume":"104","author":"Wang","year":"1998","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0162_RF20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s002770050445","article-title":"High levels of thrombopoietin in sera of patients with essential thrombocythemia: cause or consequence of abnormal platelet production","volume":"77","author":"Griesshammer","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1054\/blre.2001.0162_RF21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-8652(200003)63:3<131::AID-AJH4>3.0.CO;2-#","article-title":"Stong inverse correlation between serum TPO level and platelet count in essential thrombocythemia","volume":"63","author":"Tomita","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0162_RF22","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/blood.V90.10.4031","article-title":"Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia","volume":"90","author":"Horikawa","year":"1997","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF23","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1034\/j.1600-0609.2000.90235.x","article-title":"Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates","volume":"65","author":"Yoon","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0162_RF24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM199802263380903","article-title":"Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera","volume":"338","author":"Moliterno","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0162_RF25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood.V96.2.771","article-title":"Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis","volume":"96","author":"Tefferi","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF26","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood.V96.10.3310","article-title":"Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MDGF) in essential thrombocythemia","volume":"96","author":"Axelrad","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V77.5.925.925","article-title":"Selective hypersensitivity to granulocyte-macrophage-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors","volume":"77","author":"Emanuel","year":"1991","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V83.1.99.99","article-title":"Circulating erythroid progenitors in polycythemia vera are hypersensitive to IGF-1 in vitro: studies in an improved serum-free medium","volume":"83","author":"Correa","year":"1994","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.1993.tb08271.x","article-title":"Megakaryocyte and erythroid colony formation in essential thrombocythemia and reactive thrombocytosis: diagnostic value and correlation to complications","volume":"83","author":"Juvonen","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2141.1995.tb05153.x","article-title":"The determination of spontaneous megakaryocyte colony formation in an unequivocal test for discrimination between essential thrombocythaemia and reactive thrombocytosis","volume":"90","author":"Rolovic","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF31","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V58.5.916.916","article-title":"Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell","volume":"58","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1126\/science.2982210","article-title":"Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors","volume":"227","author":"Vogelstein","year":"1985","journal-title":"Science"},{"key":"10.1054\/blre.2001.0162_RF33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2141.1989.tb04318.x","article-title":"The application of X-chromosome gene probes to the diagnosis of myeloproliferative disease","volume":"72","author":"Lucas","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF34","first-page":"258","article-title":"Clonal analysis of myeloproliferative disorders using X-linked DNA polymorphisms","volume":"4","author":"Anger","year":"1990","journal-title":"Leukemia"},{"key":"10.1054\/blre.2001.0162_RF35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V89.1.128","article-title":"Clonality analysis of hematopoiesis in essential thrombocythaemia: advantages of studying T lymphocytes and platelets","volume":"89","author":"El-Kassar","year":"1997","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF36","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.1365-2141.1997.1933010.x","article-title":"Clonal heamopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes","volume":"97","author":"Champion","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/stem.5530110613","article-title":"A novel clonality assay based on transcriptional analysis of the active X chromosome","volume":"11","author":"Prchal","year":"1993","journal-title":"Stem Cells"},{"key":"10.1054\/blre.2001.0162_RF38","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1073\/pnas.88.15.6848","article-title":"Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction","volume":"88","author":"Gilliland","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/blre.2001.0162_RF39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood.V93.2.417","article-title":"A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications","volume":"93","author":"Harrison","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood.V93.2.415","article-title":"Essential thrombocythemia: Another \u2018heterogeneous disease\u2019 better understood?","volume":"93","author":"Nimer","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF41","first-page":"9","article-title":"Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia","volume":"36","author":"Murphy","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1054\/blre.2001.0162_RF42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-996107","article-title":"Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group","volume":"23","author":"Michiels","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/blre.2001.0162_RF43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/10428199909093727","article-title":"Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients","volume":"33","author":"Aviram","year":"1999","journal-title":"Leuk Lyphoma"},{"key":"10.1054\/blre.2001.0162_RF44","first-page":"427a","article-title":"BCR-ABL transcripts detectable in all myeloproliferative states","volume":"92","author":"Singer","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF45","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood.V97.7.2187","article-title":"BCR-ABL rearrangement is not detectable in essential thrombocythemia","volume":"97","author":"Emilia","year":"2001","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF46","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood.V93.7.2420","article-title":"Patients with essential thrombocythemia do not express BCR-ABL transcripts","volume":"93","author":"Hackwell","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF47","first-page":"214","article-title":"Absence of bcr\/abl rearrangement in 41 patients with essential thrombocythemia","volume":"85","author":"Sol\u00e9","year":"2000","journal-title":"Haematologica"},{"key":"10.1054\/blre.2001.0162_RF48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V64.1.1.1","article-title":"Bleeding and thrombosis in the myeloproliferative disorders","volume":"64","author":"Schafer","year":"1984","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF49","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-2007-996125","article-title":"Microvascular disturbances, thrombosis, and bleeding in thrombocythemia: current concepts and perspectives","volume":"23","author":"Ravandi-Kashani","year":"1997","journal-title":"Semin Thromb Hemostas"},{"key":"10.1054\/blre.2001.0162_RF50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/1040-8428(94)00164-O","article-title":"Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment","volume":"20","author":"Landolfi","year":"1995","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1054\/blre.2001.0162_RF51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s002770050555","article-title":"Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemia","volume":"78","author":"Bazzan","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1054\/blre.2001.0162_RF52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.qjmed.a030135","article-title":"Clinical spectrum, investigations and treatment of Budd-Chiari syndrome","volume":"89","author":"Mahmoud","year":"1996","journal-title":"QJM"},{"key":"10.1054\/blre.2001.0162_RF53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2007-996117","article-title":"Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Bedd-Chiari syndrome or portal vein thrombosis","volume":"23","author":"De Stefano","year":"1997","journal-title":"Semin Thromb Hemostas"},{"key":"10.1054\/blre.2001.0162_RF54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2007-996110","article-title":"Neurologic and visual symptoms in essential thrombocythemia: efficacy of low-does aspirin","volume":"23","author":"Koudstaal","year":"1997","journal-title":"Semin Thromb Hemostas"},{"key":"10.1054\/blre.2001.0162_RF55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-0404.2000.102005299.x","article-title":"Neurological complications of essential thrombocytosis (ET)","volume":"102","author":"Kesler","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"10.1054\/blre.2001.0162_RF56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-2007-996109","article-title":"Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera","volume":"23","author":"Van Genderen","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/blre.2001.0162_RF57","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-0038-1653752","article-title":"Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin","volume":"73","author":"Van Genderen","year":"1995","journal-title":"Thromb Haemostas"},{"key":"10.1054\/blre.2001.0162_RF58","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1034\/j.1600-0609.2001.00367.x","article-title":"A single institutional experience with 43 pregnancies in essential thrombocythemia","volume":"66","author":"Wright","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0162_RF59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-0037-1614620","article-title":"Thrombophilic polymorphisms are common in women with fetal loss without apparent cause","volume":"82","author":"Brenner","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2001.0162_RF60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4065\/76.1.22","article-title":"A long-term retrospective study of young women with essential thrombocythemia","volume":"76","author":"Tefferi","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1054\/blre.2001.0162_RF61","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis","volume":"332","author":"Cortelazzo","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0162_RF62","first-page":"69","article-title":"Essential thrombocythemia","volume":"10","author":"Schafer","year":"1991","journal-title":"Prog Hemost Thromb"},{"key":"10.1054\/blre.2001.0162_RF63","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2007-996119","article-title":"Acquired von Willebrand disease in patients with high platelet counts","volume":"23","author":"Budde","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/blre.2001.0162_RF64","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0002-9343(92)90576-W","article-title":"Cardiac involvement in patients with myeloproliferative disorders","volume":"93","author":"Reisner","year":"1992","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0162_RF65","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","article-title":"Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera","volume":"96","author":"Falanga","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF66","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1749-6632.2001.tb03591.x","article-title":"Stem cell plasticity in muscle and bone marrow","volume":"938","author":"Goodell","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1054\/blre.2001.0162_RF67","first-page":"153","article-title":"Endothelial progenitor cells for regeneration","volume":"13","author":"Masuda","year":"2000","journal-title":"Hum Cell"},{"key":"10.1054\/blre.2001.0162_RF68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1083-8791(00)70055-3","article-title":"Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation","volume":"6","author":"Ikpeazu","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1054\/blre.2001.0162_RF69","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI12150","article-title":"Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells","volume":"107","author":"Jackson","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1054\/blre.2001.0162_RF70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0037-1616226","article-title":"The emerging role of the bone marrow-derived stem cells in (therapeutic) angiogenesis","volume":"86","author":"Carmeliet","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2001.0162_RF71","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00062752-199603050-00002","article-title":"Management of thrombocythemia","volume":"3","author":"Schafer","year":"1996","journal-title":"Curr Opin Hematol"},{"key":"10.1054\/blre.2001.0162_RF72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9343(00)00449-6","article-title":"A clinical update in polycythemia vera and essential thrombocythemia","volume":"109","author":"Tefferi","year":"2000","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0162_RF73","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C","article-title":"Life expectancy of patients with chronic nonleukemic myeloproliferative disorders","volume":"67","author":"Rozman","year":"1991","journal-title":"Cancer"},{"key":"10.1054\/blre.2001.0162_RF74","first-page":"14","article-title":"Clinical parameters for determining when and when not to treat essential thrombocythemia","volume":"36","author":"Barbui","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1054\/blre.2001.0162_RF75","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.1993.tb08272.x","article-title":"Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors","volume":"83","author":"Watson","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF76","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6","article-title":"Clinical course of essential thrombocythemia in 147 cases","volume":"66","author":"Fenaux","year":"1990","journal-title":"Cancer"},{"key":"10.1054\/blre.2001.0162_RF77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00282-997-0011-x","article-title":"Is treatment with hydroxyurea leukemogenic in patients with essential thrombocythemia? An analysis of three new cases of leukemic transformation and review of the literature","volume":"39","author":"Liozon","year":"1997","journal-title":"Hematol Cell Ther"},{"key":"10.1054\/blre.2001.0162_RF78","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0609.1994.tb01303.x","article-title":"Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications","volume":"52","author":"Weinfeld","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0162_RF79","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2141.2000.02188.x","article-title":"Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial","volume":"110","author":"Finazzi","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF80","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V91.2.616","article-title":"Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion","volume":"91","author":"Sterkers","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF81","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3.0.CO;2-6","article-title":"Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"52","author":"Nand","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0162_RF82","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood.V95.11.3589","article-title":"Acquired DNA mutations associated with in vivo hydroxyurea exposure","volume":"95","author":"Hanft","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF83","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2141.1997.3503164.x","article-title":"The effects of anagrelide on human megakaryocytopoiesis","volume":"99","author":"Solberg","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF84","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90017-6","volume":"92","year":"1992","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0162_RF85","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V97.4.863","article-title":"Long-term use of anagrelide in young patients with essential thrombocythemia","volume":"97","author":"Storen","year":"2001","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF86","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2141.2001.02584.x","article-title":"Haemopoitic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia","volume":"112","author":"Jurado","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0162_RF87","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood.V80.8.1965.1965","article-title":"Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo","volume":"80","author":"Landolfi","year":"1992","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0162_RF88","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1055\/s-0038-1649916","article-title":"Increased thromboxane biosynthesis in essential thrombocythemia","volume":"74","author":"Rocca","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2001.0162_RF89","first-page":"172","article-title":"Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera","volume":"23","author":"Tartaglia","year":"1986","journal-title":"Semin Hematol"},{"key":"10.1054\/blre.2001.0162_RF90","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0002-9343(87)90696-6","article-title":"Aspirin and risk of bleeding in patients with thrombocythemia","volume":"83","author":"Barbui","year":"1987","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0162_RF91","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-2007-996124","article-title":"European Collaboration on Low-dose Aspirin in Polycythemia (ECLAP): a randomized trial","volume":"23","author":"Landolfi","year":"1997","journal-title":"Semin Thromb Hemost"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X01901626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X01901626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T17:24:12Z","timestamp":1584465852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X01901626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0268960X01901626"],"URL":"https:\/\/doi.org\/10.1054\/blre.2001.0162","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}